High-throughput experimentation (HTE) empowers drug developers to quickly build robust platforms for scale-up. Facing constraints on their time, resources, and materials, companies leverage this approach to rapidly execute many miniaturized reactions in parallel to survey a wide range of possible reaction conditions.
